Who Owns the Big Wellness Drink Brands, and What They Paid
Twelve big companies own most of the wellness drinks on the shelf. Here is who owns what, what they paid where a number was published, and the five small brands most likely to sell next.
Senior Partnerships Manager · August 27, 2026 · 9 min read · Updated August 12, 2026

Who owns whom
Twelve parent companies, the brands they hold, and the price where one was actually published. Where a deal was never priced, it says so, because an undisclosed number is a fact about the deal and not a gap to fill with a guess.
Ordinary beer, wine and spirits are left out on purpose. The non alcoholic and functional versions from those same companies are in.
PepsiCo
Rockstar Energy in 2020, for more than 3.8 billion dollars, with no earnout structure made public. SodaStream in 2018 for 3.3 billion, at 144 dollars a share. poppi in 2025 for 1.95 billion gross, which includes about 300 million of anticipated tax benefits, so 1.65 billion net, plus an earnout nobody has seen.
It also holds a piece of Celsius rather than the company. The first cheque was 550 million dollars for about 8.5 percent in August 2022, and a later top up took it to roughly 11 percent.
Who says so: PepsiCo's own releases on Rockstar, SodaStream and poppi. The Celsius stake comes from trade press, and no primary release surfaced for it, so treat 8.5 percent as the original 2022 position and about 11 percent as where it sits now.
The Coca-Cola Company
BODYARMOR is the big one, bought in stages, 15 percent in 2018 and the rest in 2021 for 5.6 billion dollars. Kobe Bryant's estate is estimated to have made about 400 million on his 10 percent. That is the largest wellness adjacent buyout on this page.
fairlife came in 2020, 980 million for the remaining stake, after a minority position held since 2012, and it is the closest thing Coca-Cola has to a brand aimed at the weight loss drug crowd. Topo Chico in 2017 was undisclosed. Costa Coffee in 2018 was 5.1 billion, which is coffee rather than functional drinks, listed here so the picture is complete.
Then there is Monster. Coca-Cola bought 16.7 percent for 2.15 billion in 2015 and still holds it, and the stake has quietly grown to about 19 percent because Monster keeps buying back its own shares, not because Coca-Cola bought more.
Who says so: Coca-Cola's own releases on BODYARMOR, fairlife and Costa, and Monster's investor materials for the current stake.
Keurig Dr Pepper
Core Hydration in 2018 for 525 million, with Katy Perry holding equity. Nutrabolt in December 2022, 863 million cash for about 30 percent preferred equity at a 5 percent coupon, paired with a long term distribution deal. Dyla Brands in 2025, undisclosed.
GHOST is the interesting one. Sixty percent in October 2024 for about 990 million, with the remaining 40 percent due in 2028 at a price tied to 2027 performance, which implies a full company value near 1.65 billion. Keurig Dr Pepper described it as roughly a 3 times net revenue multiple.
What it bought was flavour licences, Oreo, Sour Patch Kids and Chips Ahoy, plus the team that keeps making them. There is no celebrity and no creator audience in that deal at all.
Who says so: Keurig Dr Pepper's own newsroom for GHOST and Core, and the joint release with Nutrabolt.
Two things people get wrong about Keurig Dr Pepper
It does not own Electrolit. The relationship announced in October 2023 with Grupo PiSA is a distribution agreement across most of its direct store delivery territory. No equity moved and no price was published, because nothing was bought.
It does not own Bloom Nutrition either, and the line is not even clean. Bloom belongs to Nutrabolt, which took 20 percent in January 2024 for 90 million and went majority in September 2025 for about 160 million more, buying from founder Mari Llewellyn. Keurig Dr Pepper touches Bloom only through its stake in Nutrabolt, one step removed.
If you are building a pitch list, that difference decides who you email.
Who says so: the Keurig Dr Pepper and Grupo PiSA announcement for the first, and the Nutrabolt and Bloom majority announcement for the second.
Monster Beverage
Bang Energy in 2023 for 362 million, bought out of bankruptcy after founder Jack Owoc was pushed out and the company lost a defamation judgment. That reads as cheap distressed assets rather than a purchase of an audience, because the brand had already been damaged before Monster bid.
CANarchy Craft Brewery Collective in 2022 for 330 million took Monster outside energy and into beer, with Oskar Blues and Cigar City in the box.
Who says so: Monster's own releases on both deals.
Celsius Holdings
Alani Nu in 2025, 1.8 billion gross including 150 million in tax assets, so 1.65 billion net. Celsius bought a second energy brand built by a founder, Katy Hearn, aimed at women, because its own core line was not winning that audience fast enough.
Who says so: the Celsius release.
Nestlé Health Science
Garden of Life came in 2017 inside the 2.3 billion Atrium Innovations purchase, which also brought Douglas Laboratories and Klean Athlete. Then Vital Proteins in 2020, Essentia Water in 2021 and Orgain in 2022, all undisclosed in every source we checked. yfood Labs finished in 2026, 523 million for the remaining 51 percent after holding 49 percent since 2023.
Nuun and BOOST also sit on its brand page today, and we could not date or price either one, so they are named without a deal line rather than dressed up with a guess.
Who says so: Nestlé Health Science's own brand list, plus its releases on Atrium and yfood.
Unilever
Liquid I.V. in 2020, undisclosed, now the largest single brand inside Unilever's 1.9 billion euro health and wellbeing business, though its growth reportedly flattened in 2025. Pukka Herbs in 2017, also undisclosed, which is herbal tea and a stretch of the word beverage, included because it sits with Lipton and Pure Leaf in the same portfolio.
Who says so: Unilever's own brand pages, with the growth plateau from trade press.
Danone
The busiest buyer on this page by a wide margin, five deals in functional nutrition and ready to drink in under two years.
WhiteWave Foods closed in 2017 at 12.5 billion, which brought Silk and So Delicious. Harmless Harvest followed in 2021, Functional Formularies in 2024 and Kate Farms in 2025, all undisclosed.
Then Huel, agreed in March 2026, reported at about 1.2 billion dollars. That figure comes from press reporting and Danone's own release carried no number, so read it as reported rather than disclosed. Idris Elba backs the brand but is not a disclosed equity holder, and founder Julian Hearn holds just under half.
MADE Group, agreed in June 2026 and expected to close in the second half, was reported at about 2 billion on more than 300 million euros of sales. That price is sourced to the selling side, TPG Capital, so the same caution applies. Danone also bought the remaining 49 percent of Saputo Dairy Australia in 2026.
Who says so: Danone's own release on WhiteWave and its announcements on Huel and MADE Group. Both prices come from Food Dive, the Guardian and the Australian Financial Review, not from Danone.
Suntory
Lucozade and Ribena, bought from GlaxoSmithKline in 2013 for 1.35 billion pounds, still the core of its wellness lineup in the United Kingdom. On The Rocks in 2020 was undisclosed and is alcoholic, listed only so the portfolio is complete.
BRAND'S, the Thai wellness tonic line, sits inside Suntory today through a 2025 internal restructuring rather than a fresh purchase, so there is no deal line to give.
Who says so: Suntory's own company history and its 2025 restructuring announcement.
Constellation Brands
Two small bets, both recent, both undisclosed. HOPWTR was agreed in March 2026 and closed in early April, described as buying the remaining interest, which tells you a smaller stake came first. Hiyo took a minority cheque in February 2025 through Constellation Brands Ventures.
Neither is a big number. Both are options on the drink you have instead of a beer.
Who says so: Constellation's own announcements on both.
Anheuser-Busch InBev
BeatBox, 85 percent in 2025 for about 490 million, with a path to the rest. That one is alcoholic party punch rather than wellness, and it is here because Mark Cuban held roughly a third of it as an investor before the sale.
The one worth learning from is Hiball Energy, bought in 2017 and discontinued in 2023. A very large company bought into energy, decided the growth was not coming fast enough, and killed the brand rather than keep feeding it. It now distributes a separate energy drink, Phorm, which is a contract and not a purchase.
Who says so: the BeatBox announcement, and trade press covering the Hiball discontinuation and the Phorm distribution deal.
Molson Coors
ZOA Energy, majority in November 2024 for 53 million cash, with Dwayne Johnson as a co-founder holding equity. Fever-Tree in February 2025, an 8.5 percent stake plus exclusive rights to sell it in the United States, which makes Molson Coors its second largest shareholder. The price of the stake itself was not published anywhere we checked.
Who says so: the Molson Coors announcements on both.
What the buyers were actually paying for
Nine deals since 2023 tell one story if you read them together, and it is not the story the headlines tell.
The two biggest deals bought an audience
poppi and Alani Nu are the cleanest comparison on the shelf. Both were built by a founder on social, Allison Ellsworth at poppi and Katy Hearn at Alani Nu. Both sold for 1.65 billion net. In both cases the buyer already had the shelf space, the trucks and the money, and still could not build the audience itself.
Russell Westbrook and 24kGoldn were investors in poppi and took a cut when it sold, which is a different thing from founding it, and worth keeping straight when somebody tells you a celebrity built that brand.
Who says so: the PepsiCo and Celsius releases, with the investor payouts from trade press.
The GHOST deal bought flavours, not a face
Nearly a billion dollars for 60 percent, and the thing being bought was licensed flavour rights and an innovation team. No celebrity, no creator engine, no social audience. It is the counter example to keep in your pocket when somebody claims every drinks deal is an influencer story.
Who says so: Keurig Dr Pepper's own newsroom, including its 3 times net revenue framing.
The Bang deal bought wreckage cheaply
362 million for a brand that had been one of the loudest creator marketers in the category. By the time Monster bid, the founder was out and the company had lost a defamation case. Nobody was buying an audience there, they were buying assets at a discount after the audience had already left.
This is the part of the category that most people skip. A drinks brand can be enormous on social and still be worth a fraction of its peak two years later, and the creators who built it are the ones left explaining the association. If you are choosing who to put your brand next to, that history is worth an hour of reading, which is roughly what our functional beverage vetting playbook covers, and it is the cheapest hour in the whole process.
Who says so: the Monster release and contemporaneous reporting on the bankruptcy.
The newest pattern is a stake instead of a purchase
PepsiCo into Celsius, Keurig Dr Pepper into Nutrabolt, Constellation into Hiyo, Molson Coors into Fever-Tree. Same shape every time, a minority cheque plus a distribution deal, which is a cheap way to find out whether a brand is worth owning outright later.
Only one stake on this page has converted so far. Coca-Cola went from 15 percent of BODYARMOR in 2018 to all of it in 2021. Coca-Cola has also sat on about 19 percent of Monster for nine years without moving.
So the honest answer to whether a stake predicts a sale is that it does not. It predicts interest.
The five most likely to sell next
This section is judgement rather than fact, and the order is ours. Each pick is built on the most concrete signal available, a funding round, an existing strategic stake, a door count or a proven creator engine. Twenty four months is a horizon here, not a deadline.
Hiyo
The strongest signal on the list is structural. Constellation Brands already owns a piece of it, taken in February 2025, which is the same first move Coca-Cola made on BODYARMOR three years before buying the rest.
Everything since has pointed the same way. Live Nation as a venue partner in August 2025, a national launch across more than 510 Whole Foods stores in July 2025, Costco multi packs in January 2026, and nearly 2,000 Target stores by March 2026, with a stated plan to take total doors from about 5,000 toward 10,000.
Who says so: the Constellation Ventures stake announcement, plus trade coverage of the Live Nation partnership and the retail rollout.
Culture Pop
The category just proved a 1.65 to 1.85 billion ceiling exists for exactly this playbook, prebiotic soda sold on nostalgia and gut health, and two of the three big names have already sold. Culture Pop has raised somewhere between 36 and 57 million depending on which source you count, with the most recent round at 15.2 million in March 2025, and went nationwide in Target in April 2025 alongside Kroger, Walmart, Albertsons, Sprouts and Whole Foods, with roughly 40 percent year on year door growth.
The signal is not really about this one brand. It is that the category has room for a third player at scale, which is the same gap we wrote about in the gut health drink sponsorship gap.
Who says so: the company's own funding announcements and trade coverage of the Target launch.
Ghia
Doors went from about 750 to more than 1,600 stores, bars and restaurants in roughly two years, including a 300 location partnership with Sweetgreen, on a published raise of only 6.5 million and a reported valuation near 50 million.
Much smaller money than the rest of this list. It also owns the non alcoholic aperitif corner outright, which is the fastest growing part of the drink instead of a drink category, with a strong social engine behind it.
Who says so: trade coverage of the retail growth and the Sweetgreen partnership, plus reported valuation figures.
LMNT
The odd one out, because it is already big. About 72 million dollars through its own website alone in 2025, which understates the truth since it leaves out wholesale and Amazon, profitable, and it has taken only 5.48 million in outside money in its whole life.
That combination is what makes it interesting. Real scale, a genuine podcast and creator engine, and almost no outside investor with an exit to engineer. It is close to the profile Celsius paid 1.65 billion net for.
Who says so: company reported revenue figures and public funding records.
Cann, with a warning attached
The fastest growing hemp derived drink brand by share in California, climbing to number five in the state by June 2026 from number seven a year earlier, on 34.7 million raised and sales up about 63 percent year on year.
Now the warning. That same June data point shows month on month sales down 8.39 percent even while the year on year number stayed positive, which is what the start of a bending curve looks like. On top of that, hemp derived drinks carry live legal risk, with state crackdowns and an unsettled federal farm bill fight that could change the rules with very little notice.
This is the highest upside and the highest risk name here, and it is not a confident call.
Who says so: Headset's retail ranking data for the share figures, and public funding records for the raise.
What we could not check
Every claim above was checked against a live search this session, because a brand missing from our own files is not proof it is independent. These are the ones that did not resolve, listed rather than smoothed over.
TSG Consumer Partners and CAVU Consumer Partners both name wellness and beverage as focus areas, and neither showed a confirmed current holding in a wellness drink specifically. Suntory's BRAND'S deal history predates anything we could source. The dollar price of the Molson Coors stake in Fever-Tree was never published, only the 8.5 percent. Nuun and BOOST have no findable acquisition date or price. And we found no Coca-Cola minority stake in a wellness startup beyond Monster and the BODYARMOR path, which is absence of evidence for one session of searching rather than proof there is none.
The old 20 times sales figure attached to Casamigos is worth naming too, since it gets quoted constantly. It is an analyst estimate rather than a disclosed number, and it is spirits, so it does not belong in this conversation at all.
What this means if you sell into the category
The pattern is consistent enough to plan around. The brands that sold for the most money sold an audience, and the audience was built by creators before any buyer showed up. The brands that sold cheaply had lost that audience first.
That cuts both ways for anyone running a programme here. Twelve companies own most of the shelf, which means the brand you sign today may report to a different parent in eighteen months, and the creators you picked become somebody else's inheritance. It also means a founder led brand with a live creator engine is holding the exact asset these buyers keep paying billions for.
We build those programmes, we find and vet the creators, we handle the parts that get brands in trouble with regulators, and we keep the receipts a future buyer will want to see. If you are somewhere on this map and want a straight read on where you sit, speak with us and we will show you the deals your competitors are already running.